Compounds > azd2563
Page last updated: 2024-09-05

azd2563 and Infections, Staphylococcal

azd2563 has been researched along with Infections, Staphylococcal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acton, DG; Betts, MJ; Dennis, M; Gravestock, MB; Hatter, G; McGregor, A; Swain, ML; Wilson, RG; Woods, L; Wookey, A1
Anderegg, TR; Biedenbach, DJ; Jones, RN1
Bowker, KE; Howe, RA; MacGowan, AP; Noel, AR; Walsh, TR; Wootton, M1

Other Studies

3 other study(ies) available for azd2563 and Infections, Staphylococcal

ArticleYear
New classes of antibacterial oxazolidinones with C-5, methylene O-linked heterocyclic side chains.
    Bioorganic & medicinal chemistry letters, 2003, Dec-01, Volume: 13, Issue:23

    Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Heterocyclic Compounds; Hydrocarbons; Methane; Mice; Microbial Sensitivity Tests; Oxazolidinones; Rats; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship

2003
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:8

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus

2002
Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11

    Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance

2003